BRPI0810204A2 - Inibidores da enzina diacilglicerol o-aciltransferase tipo 1 - Google Patents
Inibidores da enzina diacilglicerol o-aciltransferase tipo 1Info
- Publication number
- BRPI0810204A2 BRPI0810204A2 BRPI0810204-0A2A BRPI0810204A BRPI0810204A2 BR PI0810204 A2 BRPI0810204 A2 BR PI0810204A2 BR PI0810204 A BRPI0810204 A BR PI0810204A BR PI0810204 A2 BRPI0810204 A2 BR PI0810204A2
- Authority
- BR
- Brazil
- Prior art keywords
- diacylglycerol
- inhibitors
- acyltransferase type
- acyltransferase
- type
- Prior art date
Links
- 102000002148 Diacylglycerol O-acyltransferase Human genes 0.000 title 1
- 108010001348 Diacylglycerol O-acyltransferase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91499907P | 2007-04-30 | 2007-04-30 | |
| PCT/US2008/061948 WO2008134690A1 (en) | 2007-04-30 | 2008-04-30 | Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0810204A2 true BRPI0810204A2 (pt) | 2014-10-14 |
Family
ID=39619098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0810204-0A2A BRPI0810204A2 (pt) | 2007-04-30 | 2008-04-30 | Inibidores da enzina diacilglicerol o-aciltransferase tipo 1 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US8076344B2 (pt) |
| EP (2) | EP2500347A1 (pt) |
| JP (1) | JP5383661B2 (pt) |
| KR (1) | KR20100019470A (pt) |
| CN (1) | CN101720327A (pt) |
| AU (1) | AU2008245458B2 (pt) |
| BR (1) | BRPI0810204A2 (pt) |
| CA (1) | CA2685524A1 (pt) |
| ES (1) | ES2392117T3 (pt) |
| IL (1) | IL201752A0 (pt) |
| MX (1) | MX2009011753A (pt) |
| NZ (2) | NZ580662A (pt) |
| RU (1) | RU2012122056A (pt) |
| SG (1) | SG171586A1 (pt) |
| WO (1) | WO2008134690A1 (pt) |
| ZA (2) | ZA200907614B (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008523133A (ja) | 2004-12-14 | 2008-07-03 | アストラゼネカ アクチボラグ | Ｄｇａｔ阻害剤としてのオキサジアゾール誘導体 |
| US7749997B2 (en) | 2005-12-22 | 2010-07-06 | Astrazeneca Ab | Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors |
| EP2301923B1 (en) | 2006-03-31 | 2016-06-08 | Novartis AG | Pyridine derivatives as dgat inhibitors |
| ATE492541T1 (de) | 2006-05-30 | 2011-01-15 | Astrazeneca Ab | Substituierte 5-phenylamino-1,3,4-oxadiazol-2- ylcarbonylamino-4-phenoxycyclohexancarbonsäuren als inhibitoren von acetylcoenzym-a- diacylglycerolacyltransferase |
| AR066169A1 (es) | 2007-09-28 | 2009-07-29 | Novartis Ag | Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat |
| EP3366686B9 (en) | 2009-03-20 | 2021-08-04 | Metabasis Therapeutics, Inc. | Inhibitors of diacylglycerol o-acyltransferase 1 (dgat-1) and uses thereof |
| US8586581B2 (en) * | 2009-12-17 | 2013-11-19 | Hoffmann-La Roche Inc | Ethynyl compounds useful for treatment of CNS disorders |
| WO2014081996A1 (en) * | 2012-11-23 | 2014-05-30 | Glaxosmithkline Llc | Novel compounds as diacylglycerol acyltransferase inhibitors |
| EA202091803A1 (ru) | 2018-02-02 | 2020-12-16 | Бёрингер Ингельхайм Интернациональ Гмбх | Производные триазолопиримидина для применения в качестве ингибиторов грелин-о-ацилтрансферазы (goat) |
| WO2021076817A2 (en) * | 2019-10-16 | 2021-04-22 | Ohio State Innovation Foundation | Methods and compositions related to treatment and prevention of cancer by inhibition of dgat1 and dgat2 |
| WO2021195425A1 (en) * | 2020-03-26 | 2021-09-30 | Sinopia Biosciences, Inc. | Isotopically-labelled trapidil derivatives |
| AU2021255495A1 (en) * | 2020-04-14 | 2022-12-15 | The Regents Of The University Of California | Substituted {1,2,4,} triazolo{1,5-a} pyrimidine compounds and use in stabilizing microtubules |
| HUE069479T2 (hu) | 2020-05-22 | 2025-04-28 | Boehringer Ingelheim Int | Alkil 7-amino-5-metil-[1,2,5]-oxadiazolo[3,4-b]piridin-karboxilát folyamatos elõállítási eljárása |
| JP2024177750A (ja) * | 2023-06-12 | 2024-12-24 | 信越化学工業株式会社 | 二環式アセチレンアルコール化合物、付加硬化型シリコーン組成物、及び熱伝導性付加硬化型シリコーン組成物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2779799A (en) | 1953-05-12 | 1957-01-29 | Abbott Lab | 1-cyclobutyl-1-ethynyl-ethanol-1 |
| US6100077A (en) | 1998-10-01 | 2000-08-08 | The Trustees Of Columbia University In The City Of New York | Isolation of a gene encoding diacylglycerol acyltransferase |
| CA2359041A1 (en) * | 1999-01-29 | 2000-08-03 | Sumitomo Chemical Co., Ltd. | Fat accumulation inhibitory agents |
| AU2079901A (en) | 1999-12-06 | 2001-06-12 | Smithkline Beecham Corporation | Thrombopoietin mimetics |
| JP2003189895A (ja) * | 2001-12-27 | 2003-07-08 | Sumitomo Chem Co Ltd | マラリア原虫増殖抑制能力の検定方法 |
| AR044152A1 (es) * | 2003-05-09 | 2005-08-24 | Bayer Corp | Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad |
| WO2006078676A2 (en) | 2005-01-19 | 2006-07-27 | Merck & Co., Inc. | Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| WO2006092414A1 (de) * | 2005-03-01 | 2006-09-08 | Basf Aktiengesellschaft | 5,6-dialkyl-7-amino-azolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel |
| EP1856122A2 (de) | 2005-03-02 | 2007-11-21 | Basf Aktiengesellschaft | 2-substituierte 7-amino-azolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel |
| NZ597247A (en) * | 2006-11-29 | 2013-06-28 | Abbott Lab | Inhibitors of diacylglycerol O-acylotransferase type 1 enzyme |
-
2008
- 2008-04-30 NZ NZ580662A patent/NZ580662A/en not_active IP Right Cessation
- 2008-04-30 ES ES08747140T patent/ES2392117T3/es active Active
- 2008-04-30 CN CN200880022922A patent/CN101720327A/zh active Pending
- 2008-04-30 JP JP2010506584A patent/JP5383661B2/ja not_active Expired - Fee Related
- 2008-04-30 AU AU2008245458A patent/AU2008245458B2/en not_active Ceased
- 2008-04-30 NZ NZ596724A patent/NZ596724A/xx not_active IP Right Cessation
- 2008-04-30 EP EP12155361A patent/EP2500347A1/en not_active Withdrawn
- 2008-04-30 KR KR1020097024999A patent/KR20100019470A/ko not_active Ceased
- 2008-04-30 WO PCT/US2008/061948 patent/WO2008134690A1/en not_active Ceased
- 2008-04-30 MX MX2009011753A patent/MX2009011753A/es active IP Right Grant
- 2008-04-30 EP EP08747140A patent/EP2142552B1/en active Active
- 2008-04-30 SG SG201102806-5A patent/SG171586A1/en unknown
- 2008-04-30 US US12/112,643 patent/US8076344B2/en not_active Expired - Fee Related
- 2008-04-30 BR BRPI0810204-0A2A patent/BRPI0810204A2/pt not_active IP Right Cessation
- 2008-04-30 CA CA002685524A patent/CA2685524A1/en not_active Abandoned
-
2009
- 2009-10-25 IL IL201752A patent/IL201752A0/en unknown
- 2009-10-29 ZA ZA2009/07614A patent/ZA200907614B/en unknown
-
2011
- 2011-10-20 US US13/277,909 patent/US8557828B2/en not_active Expired - Fee Related
-
2012
- 2012-04-18 ZA ZA2012/02856A patent/ZA201202856B/en unknown
- 2012-05-28 RU RU2012122056/04A patent/RU2012122056A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ596724A (en) | 2013-06-28 |
| CA2685524A1 (en) | 2008-11-06 |
| IL201752A0 (en) | 2010-06-16 |
| ZA200907614B (en) | 2013-06-26 |
| EP2142552B1 (en) | 2012-08-01 |
| SG171586A1 (en) | 2011-06-29 |
| ES2392117T3 (es) | 2012-12-04 |
| ZA201202856B (en) | 2015-01-28 |
| US20080293713A1 (en) | 2008-11-27 |
| AU2008245458A1 (en) | 2008-11-06 |
| US20120041003A1 (en) | 2012-02-16 |
| WO2008134690A1 (en) | 2008-11-06 |
| RU2012122056A (ru) | 2013-12-10 |
| EP2500347A1 (en) | 2012-09-19 |
| KR20100019470A (ko) | 2010-02-18 |
| AU2008245458B2 (en) | 2013-01-10 |
| MX2009011753A (es) | 2009-12-01 |
| JP5383661B2 (ja) | 2014-01-08 |
| US8557828B2 (en) | 2013-10-15 |
| CN101720327A (zh) | 2010-06-02 |
| RU2009144116A (ru) | 2011-06-10 |
| JP2010526083A (ja) | 2010-07-29 |
| US8076344B2 (en) | 2011-12-13 |
| EP2142552A1 (en) | 2010-01-13 |
| NZ580662A (en) | 2012-01-12 |
| HK1133644A1 (en) | 2010-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0810204A2 (pt) | Inibidores da enzina diacilglicerol o-aciltransferase tipo 1 | |
| BRPI0810719A2 (pt) | Inibidores da enzima diacilglicerol o-acetiltansferase tipo 1 | |
| BRPI0719352A2 (pt) | inibidores de enzima diacilglicerol o-aciltransferase tipo 1 | |
| BRPI0817656A2 (pt) | Inibidores da triazolpiridina 11-beta hidroxiesteroide desidrogenase tipo i | |
| CY2018030I2 (el) | Φαρμακοτεχνικη μορφη 514 | |
| CY2017016I2 (el) | Αναστολεις πρωτεασωματος | |
| EP2280916A4 (en) | HYDROCHLORFLUOROLEFINZUSAMMENSETZUNGEN | |
| ME01423B (me) | Fungicidni sastavi | |
| BRPI0817315A2 (pt) | Inibidores de quinase do tipo polo | |
| EP2090140A4 (en) | CHARGING DIAGRAM | |
| BRPI0820020A2 (pt) | Material anticorrosão | |
| DK2277509T3 (da) | DPP IV inhibitorformuleringer | |
| BRPI0814797A2 (pt) | Inibidores dna-pk | |
| BRPI0717460A2 (pt) | Composições de inibidores de chk1 | |
| DK3425646T3 (da) | Højspændingstransformer | |
| BRPI0814188A2 (pt) | Formulações | |
| DK2187759T3 (da) | Erythritolbaserede hårde overtræk | |
| IT1391986B1 (it) | Ciabatta di tipo perfezionato | |
| DK2161203T3 (da) | Opbevaringskasse | |
| DE602008002161D1 (de) | Münzstangen-Aufbewahrung | |
| DK2214640T3 (da) | Intranasale sammensætninger | |
| EP2176386A4 (en) | UPPER CARBURETOR | |
| NO20090054L (no) | Antitumoral dihydropyran-2-on sammensetninger | |
| BRPI0819628A2 (pt) | partículas anticorrosivas | |
| DK2092537T3 (da) | Højspændingskabel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: ABBVIE INC. (US) |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |